ADAM12

From WikiMD's Wellness Encyclopedia

  1. ADAM12

ADAM12, also known as A Disintegrin And Metalloproteinase 12, is a member of the ADAM family of proteins. These proteins are characterized by their disintegrin and metalloproteinase domains, which are involved in a variety of biological processes, including cell adhesion, cell fusion, and proteolysis.

Structure[edit | edit source]

ADAM12 is a type I transmembrane protein that consists of several distinct domains:

  • **Pro-domain**: This domain is involved in the regulation of the protein's activity. It is cleaved off to activate the enzyme.
  • **Metalloproteinase domain**: This domain contains the catalytic site responsible for the protein's proteolytic activity.
  • **Disintegrin domain**: This domain is involved in cell-cell and cell-matrix interactions.
  • **Cysteine-rich domain**: This domain may play a role in substrate recognition.
  • **EGF-like domain**: This domain is similar to epidermal growth factor and may be involved in protein-protein interactions.
  • **Transmembrane domain**: This domain anchors the protein in the cell membrane.
  • **Cytoplasmic tail**: This domain is involved in intracellular signaling.

Function[edit | edit source]

ADAM12 is involved in several physiological and pathological processes:

  • **Cell adhesion and migration**: ADAM12 can modulate cell adhesion and migration by interacting with integrins and other cell surface proteins.
  • **Proteolysis**: It can cleave various substrates, including growth factors and cytokines, thereby regulating their activity.
  • **Cell signaling**: The cytoplasmic tail of ADAM12 can interact with intracellular signaling molecules, influencing pathways such as the MAPK and PI3K/AKT pathways.
  • **Tissue remodeling**: ADAM12 is involved in tissue remodeling processes, such as those occurring during development and wound healing.

Clinical Significance[edit | edit source]

ADAM12 has been implicated in several diseases:

  • **Cancer**: Overexpression of ADAM12 has been observed in various cancers, including breast, prostate, and liver cancer. It may promote tumor progression by enhancing cell migration and invasion.
  • **Fibrosis**: ADAM12 is involved in the development of fibrosis in organs such as the liver and lungs.
  • **Muscular dystrophy**: Mutations in the ADAM12 gene have been associated with certain forms of muscular dystrophy.

Research[edit | edit source]

Research on ADAM12 is ongoing to better understand its role in health and disease. Potential therapeutic strategies targeting ADAM12 are being explored, particularly in the context of cancer and fibrotic diseases.

Also see[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD